Vismodegib

(Erivedge®)

Vismodegib

Drug updated on 11/8/2023

Dosage FormCapsule (oral; 150 mg)
Drug ClassHedgehog pathway inhibitors
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of adults with metastatic basal cell carcinoma, or with locally advanced basal cell carcinoma that has recurred following surgery or who are not candidates for surgery and who are not candidates for radiation.